The announcement makes little sense on face value. Even if others are producing Hep C cures that aren't as wildly expensive as before, those cures don't stack up against a one-shot cure, so there's still money to be made. So what is really happening? It would be easy to come up with conspiracy theories, but ..... maybe BLT have worked out that they just don't have the money to see these clinical trials through, they won't be able to raise funds in the market (as shown by the NASDAQ debacle), so the only way forward is to do a deal with big pharma whereby big pharma funds the trials and allows BLT to make a little money if it all works. They seemed to be saying something like that in the ann. So now they will be negotiating from a seriously weak position against some of the toughest in the business. Not good.
- Forums
- ASX - By Stock
- BLT
- Ann: UPDATE ON HCV CLINICAL TRIAL
Ann: UPDATE ON HCV CLINICAL TRIAL, page-87
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online